FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2491391640> ?p ?o ?g. }

• W2491391640 endingPage "1018" @default.
• W2491391640 startingPage "1010" @default.
• W2491391640 abstract "The treatment of hyperthyroidism is aimed at improving health-related quality of life (HRQoL) and reducing morbidity and mortality. However, few studies have used validated questionnaires to assess HRQoL prospectively in such patients. The purpose of this study was to assess the impact of hyperthyroidism and its treatment on HRQoL using validated disease-specific and generic questionnaires.This prospective cohort study enrolled 88 patients with Graves' hyperthyroidism and 68 with toxic nodular goiter from endocrine outpatient clinics at two Danish university hospitals. The patients were treated with antithyroid drugs, radioactive iodine, or surgery. Disease-specific and generic HRQoL were assessed using the thyroid-related patient-reported outcome (ThyPRO) and the Medical Outcomes Study 36-item Short Form (SF-36), respectively, evaluated at baseline and six-month follow-up. The scores were compared with those from two general population samples who completed ThyPRO (n = 739) and SF-36 (n = 6638).Baseline scores for patients with Graves' hyperthyroidism and toxic nodular goiter were significantly worse than those for the general population scores on all comparable ThyPRO scales and all SF-36 scales and component summaries. ThyPRO scores improved significantly with treatment on all scales in Graves' hyperthyroidism and four scales in toxic nodular goiter, while SF-36 scores improved on five scales and both component summaries in Graves' hyperthyroidism and only one scale in toxic nodular goiter. In Graves' hyperthyroidism, large treatment effects were observed on three ThyPRO scales (Hyperthyroid Symptoms, Tiredness, Overall HRQoL) and moderate effects on three scales (Anxiety, Emotional Susceptibility, Impaired Daily Life), while moderate effects were seen in two ThyPRO scales in toxic nodular goiter (Anxiety, Overall HRQoL). However, significant disease-specific and generic HRQoL deficits persisted on multiple domains across both patient groups.Graves' hyperthyroidism and toxic nodular goiter cause severe disease-specific and generic HRQoL impairments, and HRQoL deficits persist in both patient groups six months after treatment. These data have the potential to improve communication between physicians and patients by offering realistic estimates of expected HRQoL impairments and treatment effects. Future studies should identify risk factors for persistent HRQoL deficits, compare HRQoL effects of the various therapies, and thereby aid in determining the optimal treatment strategies." @default.
• W2491391640 created "2016-08-23" @default.
• W2491391640 creator A5006370051 @default.
• W2491391640 creator A5035567252 @default.
• W2491391640 creator A5039528393 @default.
• W2491391640 creator A5044453358 @default.
• W2491391640 creator A5047388632 @default.
• W2491391640 creator A5055218622 @default.
• W2491391640 creator A5072144010 @default.
• W2491391640 creator A5085122960 @default.
• W2491391640 creator A5087446629 @default.
• W2491391640 creator A5088997898 @default.
• W2491391640 date "2016-08-01" @default.
• W2491391640 modified "2023-10-18" @default.
• W2491391640 title "Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study" @default.
• W2491391640 cites W1562308323 @default.
• W2491391640 cites W1629593198 @default.
• W2491391640 cites W1712440049 @default.
• W2491391640 cites W1944359201 @default.
• W2491391640 cites W1992049196 @default.
• W2491391640 cites W2016594484 @default.
• W2491391640 cites W2028323985 @default.
• W2491391640 cites W2040054848 @default.
• W2491391640 cites W2044108890 @default.
• W2491391640 cites W2044489693 @default.
• W2491391640 cites W2048697130 @default.
• W2491391640 cites W2049667810 @default.
• W2491391640 cites W2052304058 @default.
• W2491391640 cites W2059527510 @default.
• W2491391640 cites W2070016185 @default.
• W2491391640 cites W2071292391 @default.
• W2491391640 cites W2084728935 @default.
• W2491391640 cites W2086018880 @default.
• W2491391640 cites W2096564330 @default.
• W2491391640 cites W2098487274 @default.
• W2491391640 cites W2115012618 @default.
• W2491391640 cites W2123438362 @default.
• W2491391640 cites W2128019213 @default.
• W2491391640 cites W2132556308 @default.
• W2491391640 cites W2133732661 @default.
• W2491391640 cites W2144059299 @default.
• W2491391640 cites W2148055420 @default.
• W2491391640 cites W2151464162 @default.
• W2491391640 cites W2154711066 @default.
• W2491391640 cites W2161584149 @default.
• W2491391640 cites W2163234542 @default.
• W2491391640 cites W2171720443 @default.
• W2491391640 cites W3022564440 @default.
• W2491391640 cites W4251238445 @default.
• W2491391640 cites W4292806894 @default.
• W2491391640 doi "https://doi.org/10.1089/thy.2016.0044" @default.
• W2491391640 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27370744" @default.
• W2491391640 hasPublicationYear "2016" @default.
• W2491391640 type Work @default.
• W2491391640 sameAs 2491391640 @default.
• W2491391640 citedByCount "52" @default.
• W2491391640 countsByYear W24913916402016 @default.
• W2491391640 countsByYear W24913916402017 @default.
• W2491391640 countsByYear W24913916402018 @default.
• W2491391640 countsByYear W24913916402019 @default.
• W2491391640 countsByYear W24913916402020 @default.
• W2491391640 countsByYear W24913916402021 @default.
• W2491391640 countsByYear W24913916402022 @default.
• W2491391640 countsByYear W24913916402023 @default.
• W2491391640 crossrefType "journal-article" @default.
• W2491391640 hasAuthorship W2491391640A5006370051 @default.
• W2491391640 hasAuthorship W2491391640A5035567252 @default.
• W2491391640 hasAuthorship W2491391640A5039528393 @default.
• W2491391640 hasAuthorship W2491391640A5044453358 @default.
• W2491391640 hasAuthorship W2491391640A5047388632 @default.
• W2491391640 hasAuthorship W2491391640A5055218622 @default.
• W2491391640 hasAuthorship W2491391640A5072144010 @default.
• W2491391640 hasAuthorship W2491391640A5085122960 @default.
• W2491391640 hasAuthorship W2491391640A5087446629 @default.
• W2491391640 hasAuthorship W2491391640A5088997898 @default.
• W2491391640 hasConcept C126322002 @default.
• W2491391640 hasConcept C159110408 @default.
• W2491391640 hasConcept C187212893 @default.
• W2491391640 hasConcept C188816634 @default.
• W2491391640 hasConcept C201903717 @default.
• W2491391640 hasConcept C2776254400 @default.
• W2491391640 hasConcept C2776652619 @default.
• W2491391640 hasConcept C2779951463 @default.
• W2491391640 hasConcept C2908647359 @default.
• W2491391640 hasConcept C3020110884 @default.
• W2491391640 hasConcept C526584372 @default.
• W2491391640 hasConcept C71924100 @default.
• W2491391640 hasConcept C72563966 @default.
• W2491391640 hasConcept C99454951 @default.
• W2491391640 hasConceptScore W2491391640C126322002 @default.
• W2491391640 hasConceptScore W2491391640C159110408 @default.
• W2491391640 hasConceptScore W2491391640C187212893 @default.
• W2491391640 hasConceptScore W2491391640C188816634 @default.
• W2491391640 hasConceptScore W2491391640C201903717 @default.
• W2491391640 hasConceptScore W2491391640C2776254400 @default.
• W2491391640 hasConceptScore W2491391640C2776652619 @default.
• W2491391640 hasConceptScore W2491391640C2779951463 @default.
• W2491391640 hasConceptScore W2491391640C2908647359 @default.

• next